An Updated Review on Developing Small Molecule Kinase Inhibitors Using Computer-Aided Drug Design Approaches

Small molecule kinase inhibitors (SMKIs) are of heightened interest in the field of drug research and development. There are 79 (as of July 2023) small molecule kinase inhibitors that have been approved by the FDA and hundreds of kinase inhibitor candidates in clinical trials that have shed light on...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Linwei, Liu, Songtao, Wang, Bi, Liu, Fei, Xu, Shu, Li, Pirui, Chen, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530957/
https://www.ncbi.nlm.nih.gov/pubmed/37762253
http://dx.doi.org/10.3390/ijms241813953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530957/
https://www.ncbi.nlm.nih.gov/pubmed/37762253
http://dx.doi.org/10.3390/ijms241813953

Ejemplares similares